Despite $12 billion in losses defending the safety of glyphosate, Bayer reiterates support for the herbicide

Screenshot 2026-02-07 at 10.55.02 AM

There may be a day when Bayer Crop Science decides it needs to exit the glyphosate business, George Gough, director of stakeholder relations for Bayer Crop Science, told the annual meeting of the American Sugarbeet Growers Association. But there’s a long way to go before that decision would be made, he said.

Gough said the herbicide remained popular and generally uncontroversial until about 2015, when the International Agency for Research on Cancer declared it a probable carcinogen. IARC is not a scientific organization and did no original studies. Other groups, including the World Health Organization and regulatory bodies across the globe, including the EPA, have not joined in IARC’s findings.

Follow the latest news and policy debates on sustainable agriculture, biomedicine, and other ‘disruptive’ innovations. Subscribe to our newsletter.

However, Gough explained that IARC’s finding was enough to get trial lawyers — notably including Robert F. Kennedy Jr., who now serves as Secretary of Health and Human Services — to start looking for clients to file lawsuits over glyphosate. …

He said there is a common thread among cases in which Bayer has prevailed: “When we win, it’s because the court actually allows us to submit the science there.”

This is an excerpt. Read the original post here

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT-Image-Jun-25-2026-12_23_17-PM
No, Bill Gates did not secretly engineer ticks to promote veganism
ChatGPT-Image-Jun-23-2026-03_12_23-PM
Is cellular reprogramming junk science? Nearly 20 patients are getting eye injections in the first FDA-cleared cellular trial
ChatGPT-Image-Jun-24-2026-11_36_47-AM
Why the human genome is less a script than a puzzle
Screenshot-2026-06-15-at-1.55.27-PM
America's trust in Trump-Kennedy's CDC health recommendations is plunging
ChatGPT-Image-Jun-17-2026-10_52_43-AM
Anguished parents, doctors in tears: Utah’s long measles outbreak takes a toll
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
Screenshot 2026-06-25 at 10.55
Leading OB-GYN group challenges RFK, Jr. gutting of maternal vaccine schedule
Screenshot-2026-06-22-at-9.04.46-PM
Kennedy's nutrition prescription for medical schools: Real problem, bad cure
Screenshot-2026-06-24-at-2.57.41-PM
Viewpoint: Trump’s Reflecting Pool algae fiasco points to a bigger culprit: Climate change
Screenshot-2026-06-25-at-1.48.40-PM
Glyphosate affirmed as safe: Supreme Court rejects lawsuit claiming Roundup herbicide causes cancer, upholding EPA determination
Screenshot-2026-06-24-at-2.40.46-PM
Hegseth reversal: As Air Force flu outbreak continues to surge, military reinstitutes mandatory vaccines for recruits

Sorry. No data so far.

glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.